Information about Attana’s presentation at Stora Aktiedagen on November 29
On Tuesday, November 29 at 8.30 pm, Attana will attend Stora Aktiedagen where Teodor, CEO of Attana, will hold a 20-minute company presentation followed by a 10-minute Q&A session.
The main purpose of the presentation is to present Attana´s two business areas, Life Science and Diagnostics, and the most recent progress made in each area. Information regarding Attana´s upcoming rights issue with a subscription period running December 14–29 will also be presented.
Content:
- Attana in short
- Attana Life Science
- Attana Diagnostics
- Rights issue 2023
The event will be held digitally and can be accessed via Aktiespararna´s YouTube channel.
When: Tuesday, November 29 at 8.30 pm
Where: Hotel Birger Jarl, Tulegatan 8, Stockholm
Livestream: Aktiespararna’s YouTube-channel (Länk)
For more information, please contact:
Teodor Aastrup, CEO
teodor.aastrup@attana.com
+46 (0)8 674 57 00
The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.
About Attana
Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact sales@attana.com
